This Week in Oncology: Palliative Care Strategies and Surgical Management Techniques

This week's research highlights various interventions aimed at improving patient outcomes and management. In the European respiratory review, a meta-analysis of 6,490 patients with thoracic cancer suggested that comprehensive palliative care interventions may improve quality of life (SMD 0.25), survival (hazard ratio 0.76), and overall symptoms ^[1].

Moving toward surgical management and pain control, the European journal of surgical oncology reported on a meta-analysis of 790 patients undergoing modified radical mastectomy. The findings suggested that the PECS II technique provided significantly longer analgesia duration and lower postoperative morphine requirements compared to other methods ^[2].

Similarly, research published in the Journal of gastrointestinal cancer examined a meta-analysis involving 2,728 patients; the authors noted that the combination of polyglycolic acid (PGA) sheets and fibrin glue significantly reduced delayed bleeding risk after gastric endoscopic submucosal dissection when compared to standard care ^[3].

In the realm of diagnostic imaging and pharmacology, a meta-analysis in Neurosurgical review involving 14 studies indicated that MRI radiomics predicts TERTp mutation in glioma with an AUC of 0.79, while combined models were shown to improve accuracy to 0.82 ^[4].

Finally, the European journal of clinical pharmacology published a meta-analysis of 2,543 patients which found that cisplatin-based regimens were associated with significantly better overall survival and cancer-specific survival compared to carboplatin-based regimens in cases of advanced bladder cancer ^[5].